[1] DATHE K, SCHAEFER C.The use of medication in pregnancy[J].Deutsches Arzteblatt International, 2019, 116(46): 783-790. [2] VOLQVARTZ T, VESTERGAARD A, AAGAARD S, et al.Use of alternative medicine, ginger and licorice among Danish pregnant women-a prospective cohort study[J]. BMC Complementary and Alternative Medicine, 2019, 19(1): 5-14. [3] ZENG FD.Pharmacovigilance and clinical pharmaceutical care[J]. Chinese Journal of Pharmacoepidemiology(药物流行病学杂志), 2014, 23(12): 718-721. [4] PENG LL, WANG D, SHEN L, et al.The origin and development of pharmacovigilance[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2016, 13(7): 410-413. [5] HUANG GH, DU HR, GONG LK.Analysis of research situation in the international field of pharmacovigilance in the past five years and its enlightenment to my country[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2018, 15(5): 268-275. [6] LI DJ.An introduction to the WHO Uppsala Monitoring Center and the Swedish drug alert system and its enlightenment to the above[J]. Shanghai Food and Drug Information Research(上海食品药品监管情报研究), 2012, 3: 1-5. [7] LI J, WANG J.Med watch-adverse drug reaction reporting program on FDA website[J]. Progress in Pharmaceutical Sciences(药学进展), 2001, 25(2): 108-110. [8] SONG L, ZHANG BK.Introduction to the pharmacovigilance system in the United States and France and its enlightenment to my country[J]. China Pharmacy(中国药房), 2009, 20(14): 1043-1045. [9] ZHU XY, ZHANG WG, SUN SS, et al.The development of pharma-covigilance and bibliometric analysis in China[J]. Herald of Medicine(医药导报), 2019, 38(6): 820-825. [10] LIU PC, CHEN JM, YAO WB.Thoughts on China's pharmac-ovigilance system under the new coronavirus pneumonia epidemic[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2020, 17(7): 389-392, 398. [11] CHEN HQ, WANG ZL, ZOU SH, et al.Investigation on drug use during pregnancy[J]. Chinese Journal of Perinatal Medicine(中华围产医学杂志), 2014, 17(5): 351-353. [12] World Health Organization.The Importance of pharmac-ovigilance[M]. WHO Library: The United Kingdom, 2002. [13] BÉRARD A, ABBAS-CHORFA F, KASSAI B, et al. The French pregnancy cohort: medication use during pregnancy in the French population[J]. PLoS One, 2019, 14(7): 1-18. [14] DE WAARD M, BLOMJOUS B, HOL M, et al.Medication use during pregnancy and lactation in a dutch population[J]. Journal of Human Lactation: Official Journal of International Lactation Consultant Association, 2019, 35(1): 154-164. [15] YANG Y, CHEN C, LIU XX.Pharmacokinetic characteristics and drug safety of pregnancy drugs in the mother and fetus[J]. Herald of Medicine(医药导报), 2017, 36(9): 951-955. [16] SPAAN J, BROWN M.Can we protect the kidneys after hypertensive pregnancy?[J]. CMAJ: Canadian Medical Association Journal, 2013, 185(3): 199-200. [17] MA YY, MA LJ, GAO LX.Characteristics of drug metabolism during pregnancy and lactation[J]. Chinese Journal of Practical Gynecology and Obstetrics(中国实用妇科与产科杂志), 2008, 24(6): 462-464. [18] GLANTZ A, MARSCHALL H, MATTSSON L.Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates[J]. Hepatology, 2004, 40(2): 467-474. [19] LIAO ML, FANG F, LIU GX, et al.Influencing factors and correlation of anxiety, psychological stress sources, and psychological capital among women pregnant with a second child in Guangdong and Shandong Province[J]. Journal of Affective Disorders, 2020, 264: 115-122. [20] QIN SX, TAN YP, LU BY, et al.Survey and analysis for impact factors of psychological distress in HIV-infected pregnant women who continue pregnancy[J]. The Journal of Maternal-Fetal & Neonatal Medicine, 2019, 32(19): 3160-3167. [21] HOUBEN E, TE WINKEL B, STEEGERS E, et al.Dutch trends in the use of potentially harmful medication during pregnancy[J]. British Journal of Clinical Pharmacology, 2020, 2: 1-16. [22] DA SILVA K, FERNANDES F, DE LIMS PESSOA T, et al. Prevalence and profile of adverse drug reactions in high-risk pregnancy: a cohort study[J]. BMC Pregnancy and Childbirth, 2019, 199(1): 199-204. [23] DA COSTA T, DE ALMEIDA PIMENTA CUNHA M, DO VALE BEZERRA P, et al. Incidence of adverse drug reactions in high-risk pregnancy: a prospective cohort study in obstetric intensive care[J]. European Journal of Clinical Pharmacology, 2020, 76(2): 291-298. [24] DE OLIVEIRA-FILHO A, VIEIRA A, DA SILVA R, et al. Adverse drug reactions in high-risk pregnant women: a prospective study[J]. Saudi Pharmaceutical Journal, 2017, 25(7): 1073-1077. [25] BENEVENT J, ARAUJO M, HURAULT-DELARUE C, et al.Pharmacoepid-emiology in pregnancy[J]. Therapie, 2019, 74(2): 289-300. [26] DU BR, FENG X, SHI XJ.The implementation and impact of the US FDA's new drug use rules for pregnant women[J]. Chinese Pharmaceutical Journal(中国药学杂志), 2016, 51(12): 1049-1054. [27] SAHIN L,NALLANI SC,TASSINARI MS.Medication use in pregnancy and the pregnancy and lactation labeling rule[J]. Clinical Pharmacology and Therapeutics, 2016, 100(1): 23-25. [28] HELLWIG K, DUARTE CARON F, WICKLEIN EM, et al.Pregnancy outcomes from the global pharmacovigilance database on interferon beta-1b exposure[J]. Therapeutic Advances in Neurological Disorders, 2020, (13): 1-11. [29] BEEX-OOSTERHUIS MM, SAMB A, HEERDINK ER, et al.Safety of clozapine use during pregnancy: analysis of international pharmacovigilance data[J]. Pharmacoepidemiology and Drug Safety, 2020, 29(6): 725-735. [30] ONKEN M, MICK I, SCHAEFER C.Paliperidone and pregnancy-an evaluation of the German embryotox database[J]. Arch Womens Ment Health, 2018, 21(6): 657-662. [31] DANET C,ARAUJO M, BOS-THOMPSON MA, et al.Pregnancy outcomes in women exposed to cancer chemotherapy[J]. Pharm-acoepidemiology and Drug Safety, 2018, 27(12): 1302-1308. [32] ZHOU W, LIU AL, DU GH.Comparative study on adverse drug reaction monitoring systems between China and the United Kingdom[J]. Chinese Journal of Drug Evaluation, 2015, 32(6): 376-380. |